Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,610,300 | 747,500 | 3,695,700 | 3,047,800 | 2,017,600 |
| Depreciation Amortization | 694,600 | 512,000 | 682,700 | 505,300 | 325,100 |
| Income taxes - deferred | -20,500 | 76,100 | -175,000 | -56,800 | -30,200 |
| Accounts receivable | -301,200 | -195,700 | -241,400 | -238,100 | -65,000 |
| Other Working Capital | -1,140,800 | -1,155,500 | 125,200 | -654,100 | -411,500 |
| Other Operating Activity | 562,000 | 250,800 | 500,000 | 401,200 | 178,000 |
| Operating Cash Flow | $1,404,400 | $235,200 | $4,587,200 | $3,005,300 | $2,014,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -407,700 | -210,000 | -616,100 | -434,000 | -263,700 |
| Net Acquisitions | -600,000 | -300,000 | -1,200,000 | -900,000 | -600,000 |
| Purchase Of Investment | -2,536,000 | -1,256,700 | -7,913,200 | -5,631,700 | -3,833,300 |
| Sale Of Investment | 3,584,500 | 1,884,300 | 7,378,900 | 5,185,800 | 2,823,600 |
| Purchase Sale Intangibles | -980,300 | -855,200 | -111,600 | -110,400 | 0 |
| Other Investing Activity | -987,500 | -861,800 | -134,400 | -123,200 | -65,900 |
| Investing Cash Flow | $-946,700 | $-744,200 | $-2,484,800 | $-1,903,100 | $-1,939,300 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -2,700 | -2,700 | N/A |
| Common Stock Issued | -17,800 | -25,500 | -8,500 | -12,400 | -21,900 |
| Common Stock Repurchased | -1,365,400 | -583,600 | -1,000,000 | -348,900 | 0 |
| Other Financing Activity | -269,200 | -292,300 | -41,400 | 37,900 | 1,100 |
| Financing Cash Flow | $-1,652,400 | $-901,400 | $-1,052,600 | $-326,100 | $-20,800 |
| Exchange Rate Effect | 37,800 | 7,900 | -31,300 | 700 | 100 |
| Beginning Cash Position | 2,326,500 | 2,326,500 | 1,308,000 | 1,308,000 | 1,308,000 |
| End Cash Position | 1,169,600 | 924,000 | 2,326,500 | 2,084,800 | 1,362,000 |
| Net Cash Flow | $-1,156,900 | $-1,402,500 | $1,018,500 | $776,800 | $54,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,404,400 | 235,200 | 4,587,200 | 3,005,300 | 2,014,000 |
| Capital Expenditure | -407,700 | -210,000 | -616,100 | -434,000 | -263,700 |
| Free Cash Flow | 996,700 | 25,200 | 3,971,100 | 2,571,300 | 1,750,300 |